New pill targets tough cancers: early trial begins
NCT ID NCT05163028
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 18 times
Summary
This early-phase study tests an experimental oral drug, HBI-2376, in adults with advanced solid tumors (like lung, colon, or pancreatic cancer) that have specific KRAS or EGFR gene mutations. The main goal is to find the safest dose and check for side effects. About 42 participants whose cancer has not responded to standard treatments will take the drug to see if it can help control their disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BRCR Medical Center
Plantation, Florida, 33322, United States
-
California Cancer Associates for Research and Excellence, Inc. (cCare)
Encinitas, California, 92024, United States
-
California Cancer Associates for Research and Excellence, Inc. (cCare)
San Marcos, California, 92069, United States
-
City of Hope
Duarte, California, 91010, United States
-
Gabrail Cancer Center
Canton, Ohio, 44718, United States
-
Orlando Health, Inc.
Orlando, Florida, 32806, United States
-
Pan American Center for Oncology Trials (PanOncology Trials)
Rio Piedras, Puerto Rico, 00935, Puerto Rico
-
Providence Medical Foundation
Fullerton, California, 92835, United States
-
Sarcoma Oncology
Santa Monica, California, 90403, United States
-
Texas Oncology - Tyler
Tyler, Texas, 75702, United States
-
UCLA Hematology/Oncology
Santa Monica, California, 90404, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.